Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Senti Biosciences, Inc. (SNTI) had Normalized Income after Taxes of $-52.79M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-52.79M |
|
-- |
|
-- |
|
$61.04M |
|
$-61.04M |
|
$8.25M |
|
$-52.79M |
|
$-52.79M |
|
$-52.79M |
|
$-52.79M |
|
$-52.79M |
|
|
Normalized Income after Taxes |
$-52.79M |
$-61.04M |
|
$-55.19M |
|
4.60M |
|
4.60M |
|
$-12.03 |
|
$-12.03 |
|
| Balance Sheet Financials | |
$58.96M |
|
$21.29M |
|
$38.88M |
|
$97.84M |
|
$13.15M |
|
-- |
|
$59.05M |
|
$72.19M |
|
$25.65M |
|
$25.65M |
|
$25.65M |
|
4.83M |
|
| Cash Flow Statement Financials | |
$-41.40M |
|
$0.03M |
|
$53.73M |
|
$39.45M |
|
$51.81M |
|
$12.37M |
|
$1.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.49 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-205.82% |
|
-205.82% |
|
-53.95% |
|
-205.82% |
|
$5.31 |
|
$-9.00 |
|
$-9.01 |
|